-58%

est. 2Y upside i

HealthcareAI & MLSeries A

We build the AI companion for nurses, to create time for care.

Rank

#348

Sector

Healthtech, Artificial Intelligence, Speech Recognition

Est. Liquidity

~4Y

Data Quality

Data: High

voize operates in a massive and growing healthtech market, addressing a critical pain point for nurses with a proven AI-powered solution.

Last updated: March 10, 2026

Bull (35%)+400%

voize successfully expands into the US market, securing major partnerships with large skilled nursing facility chains and hospitals. Its specialized AI for nursing documentation becomes the industry standard, fending off competitors due to deep EHR integration and superior language models. Revenue scales to over $100M by 2028, justifying a $1B+ valuation at a 10x+ revenue multiple, well above the current $200M.

Base (25%)+80%

voize continues its strong growth in Europe and achieves moderate traction in the US, maintaining its niche in skilled nursing facilities. While facing increased competition, its proprietary AI and existing customer base provide a solid foundation. Revenue grows to ~$40M by 2028, leading to an acquisition or Series B/C valuation of approximately $360M.

Bear (40%)-80%

Dominant EHR providers like Epic or tech giants like Microsoft (with Nuance) aggressively enter the nursing documentation space with competing AI solutions, commoditizing the market. voize struggles to gain significant US market share, leading to slower-than-expected growth and a down round. Valuation drops to $40M, severely impacting common stock value given the $60M in liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Investors hold $60M in liquidation preferences. In an exit at or below the estimated $200M valuation, common stock holders would see significantly reduced returns or potentially nothing.

Dilution Risk

moderate

As a Series A company, voize will likely require at least one to two more significant funding rounds (Series B, C) before a liquidity event, implying further dilution for existing equity holders.

Secondary Liquidity

none

There is no indication of an active secondary market or tender offers for voize equity at this stage.

Customer Support — 2 roles

Business Development — 1 role

Operations — 1 role

Partnership — 1 role

View all 23 open roles at voize →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on voize's data — designed to show you've done your homework.

  • 1

    “Abridge has gained significant traction with major health systems, including for nursing documentation. How does voize plan to differentiate and compete effectively against such well-funded and established players, particularly in the US market?”

  • 2

    “Given the ambitious goal of expanding into the US market, what are the specific milestones and challenges you anticipate in adapting your AI companion to American healthcare workflows and navigating the regulatory landscape?”

  • 3

    “With a recent Series A round, what is the company's projected timeline for future funding rounds and potential liquidity events, and how does the current preference stack impact the expected returns for common stock holders?”

Community

Valuation Sentiment

Our model estimates -58% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.